{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T22:30:04Z","timestamp":1696545004936},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ijid.2013.03.012","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T14:22:51Z","timestamp":1367331771000},"page":"e1022-e1024","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel"],"prefix":"10.1016","volume":"17","author":[{"given":"Shmuel","family":"Stienlauf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vered","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eilat","family":"Shinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yechezkel","family":"Sidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gad","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2013.03.012_bib0005","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","article-title":"Human T-lymphotropic virus 1: recent knowledge about an ancient infection","volume":"7","author":"Verdonck","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2013.03.012_bib0010","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ijid.2013.03.012_bib0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Gon\u00e7alves","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2013.03.012_bib0020","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3201\/eid1507.080796","article-title":"Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel","volume":"15","author":"Stienlauf","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2013.03.012_bib0025","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1086\/424598","article-title":"Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers","volume":"190","author":"Hisada","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.03.012_bib0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00126334-200303010-00013","article-title":"Human T-cell lymphotropic virus type I (HTLV-I)-related clinical and laboratory findings for HTLV-I-infected blood donors","volume":"32","author":"Furukawa","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2013.03.012_bib0035","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1086\/514143","article-title":"Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group","volume":"176","author":"Murphy","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.03.012_bib0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00053124","article-title":"Follow-up of asymptomatic HTLV-I carriers among blood donors in Kyushu, Japan","volume":"2","author":"Tokudome","year":"1991","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ijid.2013.03.012_bib0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/QAI.0b013e3181cc5481","article-title":"Increased all-cause and cancer mortality in HTLV-II infection","volume":"54","author":"Biswas","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2013.03.012_bib0050","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM199308193290816","article-title":"HTLV tax and mycosis fungoides","volume":"329","author":"Pancake","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2013.03.012_bib0055","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1172\/JCI117697","article-title":"The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients","volume":"95","author":"Pancake","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijid.2013.03.012_bib0060","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1046\/j.1365-2141.1997.3213138.x","article-title":"Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study","volume":"98","author":"Bazarbachi","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijid.2013.03.012_bib0065","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4103\/0378-6323.53131","article-title":"Comparison of seropositivity of human T lymphotropic virus type 1 in mycosis fungoides patients and normal volunteers: a case\u2013control study and review of literature","volume":"75","author":"Seirafi","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.ijid.2013.03.012_bib0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1423-0410.1995.tb00358.x","article-title":"Is mycosis fungoides associated with HTLV-I?","volume":"69","author":"Vallejo","year":"1995","journal-title":"Vox Sang"},{"key":"10.1016\/j.ijid.2013.03.012_bib0075","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000086063","article-title":"Mycosis fungoides in European Russia: no antibodies to human T cell leukemia virus type I structural proteins, but virus-like sequences in blood and saliva","volume":"48","author":"Morozov","year":"2005","journal-title":"Intervirology"},{"key":"10.1016\/j.ijid.2013.03.012_bib0080","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijid.2013.03.012_bib0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.ijid.2013.03.012_bib0090","first-page":"107","article-title":"Human T-cell leukemia virus type I infection as an oncogenic and prognostic risk factor in cervical and vaginal carcinoma","volume":"77","author":"Miyazaki","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijid.2013.03.012_bib0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ijc.2910610105","article-title":"Human T-cell lymphotropic virus type I and severe neoplasia of the cervix in Jamaica","volume":"61","author":"Strickler","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijid.2013.03.012_bib0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00007435-200307000-00009","article-title":"Chlamydia trachomatis, herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients","volume":"30","author":"Castle","year":"2003","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ijid.2013.03.012_bib0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1349-7006.1994.tb02087.x","article-title":"Mortality among inhabitants of an HTLV-I endemic area in Japan","volume":"85","author":"Iwata","year":"1994","journal-title":"Jpn J Cancer Res"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971213001410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971213001410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T07:54:02Z","timestamp":1539676442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971213001410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1201971213001410"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2013.03.012","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2013.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}